Detalles de la búsqueda
1.
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy.
Proc Natl Acad Sci U S A
; 117(1): 541-551, 2020 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31889004
2.
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors.
Breast Cancer Res Treat
; 167(3): 635-648, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29086231
3.
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance.
Breast Cancer Res Treat
; 167(2): 459-468, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29063312
4.
Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA).
Mol Cell Proteomics
; 14(10): 2775-85, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26106084
5.
Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.
Front Immunol
; 15: 1285049, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38455061
6.
A Composite Decision Rule of CD8+ T-cell Density in Tumor Biopsies Predicts Efficacy in Early-stage, Immunotherapy Trials.
Clin Cancer Res
; 30(4): 877-882, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38127293
7.
Facts and Hopes on Biomarkers for Successful Early Clinical Immunotherapy Trials: Innovative Patient Enrichment Strategies.
Clin Cancer Res
; 30(8): 1448-1456, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100047
8.
Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition.
Sci Transl Med
; 13(598)2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34135110
9.
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.
PLoS One
; 14(7): e0219517, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31291357
10.
Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-18F-Fluorothymidine Uptake After Therapy in a Colorectal Cancer Model.
J Nucl Med
; 59(7): 1063-1069, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29476002
11.
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.
Sci Rep
; 7(1): 18086, 2017 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29273809
12.
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.
MAbs
; 8(4): 811-27, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26984378
13.
Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma.
Leuk Lymphoma
; 55(9): 2151-5160, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24304419
14.
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy.
Mol Oncol
; 7(6): 1142-51, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24055141
Resultados
1 -
14
de 14
1
Próxima >
>>